|
|
Volumn 105, Issue 7, 2008, Pages 661-668
|
|
Intravitreal administration of triamcinolone and bevacizumab for pigment epithelial detachment in conjunction with AMD;Intravitreales triamcinolon und bevacizumab bei pigmentepithelabhebung im rahmen der AMD
a
|
|
Author keywords
Bevacizumab; Natural outcome; Serous pigment epithelial detachment; Triamcinolone
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTIINFLAMMATORY AGENT;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
TRIAMCINOLONE;
AGED;
ARTICLE;
CLINICAL TRIAL;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
HUMAN;
INJECTION;
MALE;
RETINA DETACHMENT;
RETINA MACULA DEGENERATION;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
VITREOUS BODY;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
INJECTIONS;
MACULAR DEGENERATION;
MALE;
RETINAL DETACHMENT;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
TRIAMCINOLONE;
VITREOUS BODY;
|
|
EID: 47849096396
PISSN: 0941293X
EISSN: None
Source Type: Journal
DOI: 10.1007/s00347-007-1655-1 Document Type: Article |
|
Times cited : (6)
|
|
References (30)
|
